258 related articles for article (PubMed ID: 32328201)
1. MiRNAs in Radiotherapy Resistance of Nasopharyngeal Carcinoma.
Tian Y; Tang L; Yi P; Pan Q; Han Y; Shi Y; Rao S; Tan S; Xia L; Lin J; Oyang L; Tang Y; Liang J; Luo X; Liao Q; Wang H; Zhou Y
J Cancer; 2020; 11(13):3976-3985. PubMed ID: 32328201
[TBL] [Abstract][Full Text] [Related]
2. Integrated analysis of the differential cellular and EBV miRNA expression profiles in microdissected nasopharyngeal carcinoma and non-cancerous nasopharyngeal tissues.
Wan XX; Yi H; Qu JQ; He QY; Xiao ZQ
Oncol Rep; 2015 Nov; 34(5):2585-601. PubMed ID: 26330189
[TBL] [Abstract][Full Text] [Related]
3. BART miRNAs: an unimaginable force in the development of nasopharyngeal carcinoma.
Wang Y; Guo Z; Shu Y; Zhou H; Wang H; Zhang W
Eur J Cancer Prev; 2017 Mar; 26(2):144-150. PubMed ID: 26909566
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs as Therapeutic Targets in Nasopharyngeal Carcinoma.
Wang S; Claret FX; Wu W
Front Oncol; 2019; 9():756. PubMed ID: 31456943
[TBL] [Abstract][Full Text] [Related]
5. miR-504 mediated down-regulation of nuclear respiratory factor 1 leads to radio-resistance in nasopharyngeal carcinoma.
Zhao L; Tang M; Hu Z; Yan B; Pi W; Li Z; Zhang J; Zhang L; Jiang W; Li G; Qiu Y; Hu F; Liu F; Lu J; Chen X; Xiao L; Xu Z; Tao Y; Yang L; Bode AM; Dong Z; Zhou J; Fan J; Sun L; Cao Y
Oncotarget; 2015 Jun; 6(18):15995-6018. PubMed ID: 26201446
[TBL] [Abstract][Full Text] [Related]
6. Circular RNAs in nasopharyngeal carcinoma.
Yang M; Huang W
Clin Chim Acta; 2020 Sep; 508():240-248. PubMed ID: 32417214
[TBL] [Abstract][Full Text] [Related]
7. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
[TBL] [Abstract][Full Text] [Related]
8. Study of the correlationship link between microRNAs and nasopharyngeal carcinoma.
Xu XH; Liu Y
Saudi Med J; 2014 Apr; 35(4):329-35. PubMed ID: 24749128
[TBL] [Abstract][Full Text] [Related]
9. Functions of microRNA-143 in the apoptosis, invasion and migration of nasopharyngeal carcinoma.
Chen JH; Yang R; Zhang W; Wang YP
Exp Ther Med; 2016 Dec; 12(6):3749-3755. PubMed ID: 28101165
[TBL] [Abstract][Full Text] [Related]
10. The role of microRNAs in nasopharyngeal carcinoma.
Tan G; Tang X; Tang F
Tumour Biol; 2015 Jan; 36(1):69-79. PubMed ID: 25427638
[TBL] [Abstract][Full Text] [Related]
11. The emerging roles of exosomal miRNAs in nasopharyngeal carcinoma.
Liao C; Liu H; Luo X
Am J Cancer Res; 2021; 11(6):2508-2520. PubMed ID: 34249413
[TBL] [Abstract][Full Text] [Related]
12. Small biomarkers with massive impacts: PI3K/AKT/mTOR signalling and microRNA crosstalk regulate nasopharyngeal carcinoma.
Li HL; Deng NH; He XS; Li YH
Biomark Res; 2022 Jul; 10(1):52. PubMed ID: 35883139
[TBL] [Abstract][Full Text] [Related]
13. An integrative transcriptomic analysis reveals p53 regulated miRNA, mRNA, and lncRNA networks in nasopharyngeal carcinoma.
Gong Z; Yang Q; Zeng Z; Zhang W; Li X; Zu X; Deng H; Chen P; Liao Q; Xiang B; Zhou M; Li X; Li Y; Xiong W; Li G
Tumour Biol; 2016 Mar; 37(3):3683-95. PubMed ID: 26462838
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-19b-3p regulates nasopharyngeal carcinoma radiosensitivity by targeting TNFAIP3/NF-κB axis.
Huang T; Yin L; Wu J; Gu JJ; Wu JZ; Chen D; Yu HL; Ding K; Zhang N; Du MY; Qian LX; Lu ZW; He X
J Exp Clin Cancer Res; 2016 Dec; 35(1):188. PubMed ID: 27919278
[TBL] [Abstract][Full Text] [Related]
15. Identification of miRNA/mRNA-Negative Regulation Pairs in Nasopharyngeal Carcinoma.
Liu M; Zhu K; Qian X; Li W
Med Sci Monit; 2016 Jun; 22():2215-34. PubMed ID: 27350400
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs serving as potential biomarkers and therapeutic targets in nasopharyngeal carcinoma: A critical review.
Lee KT; Tan JK; Lam AK; Gan SY
Crit Rev Oncol Hematol; 2016 Jul; 103():1-9. PubMed ID: 27179594
[TBL] [Abstract][Full Text] [Related]
17. Involvement of Non-Coding RNAs in Chemo- and Radioresistance of Nasopharyngeal Carcinoma.
Xiao J; He X
Cancer Manag Res; 2021; 13():8781-8794. PubMed ID: 34849030
[TBL] [Abstract][Full Text] [Related]
18. MiR-99a inhibits cell proliferation of nasopharyngeal carcinoma by targeting mTOR and serves as a prognostic factor.
Wu SH; Han L; Lu BC; Wang HY; Zheng CP
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2053-2061. PubMed ID: 30915749
[TBL] [Abstract][Full Text] [Related]
19. High expression of Ki-67 acts a poor prognosis indicator in locally advanced nasopharyngeal carcinoma.
Zhao Y; Shen L; Huang X; Jing D; Huang D; Fu J; Li Z; Zhang G; Shen L
Biochem Biophys Res Commun; 2017 Dec; 494(1-2):390-396. PubMed ID: 28947213
[TBL] [Abstract][Full Text] [Related]
20. EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways.
Lin C; Zong J; Lin W; Wang M; Xu Y; Zhou R; Lin S; Guo Q; Chen H; Ye Y; Zhang B; Pan J
J Exp Clin Cancer Res; 2018 Nov; 37(1):283. PubMed ID: 30477559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]